High Level of Soluble CD146 In Cerebrospinal Fluid Might be a Biomarker of Severity of Anti-N-Methyl-D-Aspartate Receptor Encephalitis
BackgroundDisruption of the blood–brain barrier (BBB) is an important pathophysiological process of anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis. A recent multi-center study showed that soluble (s) CD146 is a potential biomarker for monitoring early BBB damage and central nervous sys...
Main Authors: | Qing Li, Jinglong Chen, Mengzhuo Yin, Jun Zhao, Fuchang Lu, Zhanhang Wang, Xiaoqi Yu, Shuangyan Wang, Dong Zheng, Honghao Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-06-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.680424/full |
Similar Items
-
Elevated Serum and Cerebrospinal Fluid CD138 in Patients With Anti-N-Methyl-d-Aspartate Receptor Encephalitis
by: Jiajia Zhu, et al.
Published: (2019-05-01) -
Cerebrospinal fluid light and heavy neurofilament level increased in anti‐N‐methyl‐d‐aspartate receptor encephalitis
by: Jiayu Li, et al.
Published: (2019-08-01) -
Current Status of Biomarkers in Anti-N-Methyl-D-Aspartate Receptor Encephalitis
by: Nicolás Lundahl Ciano-Petersen, et al.
Published: (2021-12-01) -
Anti-NMDAR encephalitis, a mimicker of acute infectious encephalitis and a review of the literature
by: Darren Wong, et al.
Published: (2014-01-01) -
Higher CSF Levels of NLRP3 Inflammasome Is Associated With Poor Prognosis of Anti-N-methyl-D-Aspartate Receptor Encephalitis
by: Yu Peng, et al.
Published: (2019-05-01)